Antibody Drug Conjugates Contract Manufacturing Market

Antibody Drug Conjugates Contract Manufacturing Market Size, Share, Growth Analysis, By Condition(Myeloma, Lymphoma), By Linker(Cleavable Linker, Non-cleavable Linker), By Region(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35H2138 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Antibody Drug Conjugates Contract Manufacturing Market Insights

Market Overview:

In 2022, the global market for antibody drug conjugates (ADCs) contract manufacturing reached a substantial valuation of USD 9.75 billion, indicating remarkable growth. This growth can be attributed to the increasing demand for targeted cancer therapies and the expanding pipeline of ADC-based drugs. ADCs combine the specificity of antibodies with the cytotoxic properties of drug payloads, offering enhanced efficacy and reduced side effects in cancer treatment. Contract manufacturing organizations (CMOs) play a critical role in the production and development of ADCs, providing specialized expertise and infrastructure for the manufacturing process. The market expansion is further driven by advancements in biopharmaceutical manufacturing technologies and the increasing outsourcing of ADC production by pharmaceutical companies. With the continuous advancement in ADC research and development, the global ADC contract manufacturing market is anticipated to witness sustained growth in the foreseeable future.

Antibody Drug Conjugates Contract Manufacturing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for Antibody Drug Conjugates Contract Manufacturing was estimated to be valued at US$ XX Mn in 2021.

The global Antibody Drug Conjugates Contract Manufacturing Market is estimated to grow at a CAGR of XX% by 2028.

The global Antibody Drug Conjugates Contract Manufacturing Market is segmented on the basis of Condition, Linker, Region.

Based on region, the global Antibody Drug Conjugates Contract Manufacturing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global Antibody Drug Conjugates Contract Manufacturing Market are Sterling, Recipharm AB, Lonza, Catalent, Inc., Sartorius AG, Wuxi Biologics, Samsung BioLogics, Piramal Group (Piramal Pharma Solutions), Abbvie, Inc. (Abbvie Contract Manufacturing), Merck KGaA.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Antibody Drug Conjugates Contract Manufacturing Market

Product ID: UCMIG35H2138

$5,300
BUY NOW GET FREE SAMPLE